معرفی
Mattia Galli is a Researcher at the Department of Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome. He teaches courses including Cardiovascular Instrumental Diagnostics, Human Anatomy, and Clinical Nursing in Cardiovascular Disease. His academic work focuses on cardiovascular medicine and biotechnologies with a strong emphasis on clinical applications.
Dr. Galli's research spans multiple areas of cardiovascular medicine with particular expertise in:
- Antiplatelet and anticoagulant therapies
- Percutaneous coronary interventions
- Cardiovascular pharmacology
- Thrombosis and bleeding risk management
- Personalized medicine approaches in cardiology
- Platelet function and genetic testing
His recent publications (2023-2024) demonstrate a strong focus on optimizing antiplatelet therapy, particularly examining factors like genetic variations, renal function, and ethnic differences that affect treatment response. His work often involves meta-analyses and clinical trials, including several SWAP studies examining therapy switching protocols and the TAPER-S study on ischemic preconditioning. He has made significant contributions to understanding high bleeding risk scenarios, aspirin hypersensitivity, and dual pathway inhibition strategies.
Dr. Galli's research bridges the gap between pharmacological mechanisms and clinical practice, aiming to improve patient outcomes through evidence-based approaches. His work has appeared in top-tier journals including European Heart Journal, JACC, and Nature Reviews Cardiology, reflecting the high impact of his contributions to the field of cardiovascular medicine.
